Skip to main content
. 2024 Jan 2;30(5):975–983. doi: 10.1158/1078-0432.CCR-23-1829

Figure 3.

Figure 3. OS (A) and PFS (B) for Cohort 1A and Cohort 1B. NE, not evaluable; OS, overall survival; PFS, progression-free survival.

OS (A) and PFS (B) for Cohort 1A and Cohort 1B. NE, not evaluable; OS, overall survival; PFS, progression-free survival.